抗动脉增生机制和治疗方法
Alex Hudson1, Oluwakemi O Igiehon2, Matthew D Woolard2,3
1Department of Molecular and Cellular Physiology, LSU Health Sciences Center at Shreveport, Shreveport, LA, USA.
Current atherosclerosis reports
|August 20, 2025
概括
通过阻碍炎症的解消,受损的血细胞增多会使动脉样硬化恶化. 针对乳细胞和炎症的新疗法在治疗心血管疾病方面具有前景.
科学领域:
- 心血管研究
- 免疫学
- 分子生物学
背景情况:
- 动脉样硬化是一种慢性炎症疾病.
- 在动脉样硬化中,受损的细胞清除会加剧炎症和斑块不稳定.
- 巨功能障碍和代谢变化是疾病过程的核心.
研究的目的:
- 审查抗动脉生成机制,重点关注炎症解消中的血细胞分裂.
- 探索基于解决方案的动脉样硬化治疗策略.
- 突出显示巨代谢,血细胞和血管平衡之间的联系.
主要方法:
- 目前关于动脉样硬化,炎症和血细胞衰竭的文献的综述.
- 分析与巨细胞群和代谢相关的分子和细胞分析数据.
- 检查新兴的治疗策略,包括有利于解决的调解剂和疫苗.
主要成果:
- 在动脉样硬化中,受损的细胞结晶会导致斑块不稳定和死核扩张.
- 细胞形成过程中的巨细胞代谢适应对于产生溶解介质至关重要.
- 不调节的信号通路和微RNA会对血细胞和心血管结果产生负面影响.
- 基于分辨率的疗法和疫苗通过增强细胞和调节免疫反应来治疗动脉样硬化.
结论:
- 细胞分裂是动脉样硬化的炎症解消的关键调节者,它将巨细胞代谢与斑块稳定性联系起来.
- 动脉样细胞分裂导致动脉样硬化, 但新疗法有望进行干预.
- 分析和向输送系统的进步是开发动脉样硬化心血管疾病精准药物的关键.
更多相关视频
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
869
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
869
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Angina IV: Management
22
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30


